Evidence map›Paper›PMID 41257247›Full record

ArticleNAR molecular medicine2024

Intercellular mosaic methylation in fast-growing

Maryam Ahmadi Jeshvaghane, Samuel J Modlin, Derek Conkle-Gutierrez, Monica E Espinoza, Faramarz Valafar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NAR molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maryam Ahmadi JeshvaghaneLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University, San Diego, CA 92190, USA.
Samuel J ModlinLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University, San Diego, CA 92190, USA.
Derek Conkle-GutierrezLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University, San Diego, CA 92190, USA.
Monica E EspinozaLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University, San Diego, CA 92190, USA.
Faramarz ValafarLaboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University, San Diego, CA 92190, USA.ORCID https://orcid.org/0000-0002-3648-9384

Funding

Evolutionary and Functional Significance of Novel Mutations in MDR-XDR TBR01AI105185 · NIAID · SAN DIEGO STATE UNIVERSITY · PI VALAFAR, FARAMARZ · 2013 to 2021
$5.3M
Undetected Drug resistance and Tolerance in lesions of recurrent TBR01AI163202 · NIAID · SAN DIEGO STATE UNIVERSITY · PI VALAFAR, FARAMARZ · 2022 to 2025
$2.8M
NIAID NIH HHS R01 AI105185NIAID NIH HHS R01 AI163202
6 · The paper itself

Abstract

Orphan DNA adenine methyltransferases (MTases) of

Identifiers

PMID41257247
PMCPMC12430009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.